{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:09:00Z","timestamp":1790392140676,"version":"4.1.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    This report outlines the case of a child affected by a type of congenital disorder of glycosylation (CDG) known as ALG2-CDG (\n                    <jats:ext-link>OMIM 607906<\/jats:ext-link>\n                    ), presenting as a congenital myasthenic syndrome (CMS) caused by variants identified in\n                    <jats:italic>ALG2<\/jats:italic>\n                    , which encodes an \u03b11,3-mannosyltransferase (\n                    <jats:ext-link>EC 2.4.1.132<\/jats:ext-link>\n                    ) involved in the early steps of N-glycosylation. To date, fourteen cases of ALG2-CDG have been documented worldwide. From birth, the child experienced perinatal asphyxia, muscular weakness, feeding difficulties linked to an absence of the sucking reflex, congenital hip dislocation, and hypotonia. Over time, additional complications emerged, such as inspiratory stridor, gastroesophageal reflux, low intake, recurrent seizures, respiratory infections, an inability to maintain the head upright, and a global developmental delay. Whole genome sequencing (WGS) revealed the presence of two\n                    <jats:italic>ALG2<\/jats:italic>\n                    variants in compound heterozygosity: a novel variant c.1055_1056delinsTGA p.(Ser352Leufs*3) and a variant of uncertain significance (VUS) c.964C&amp;gt;A p.(Pro322Thr). Additional studies, including determination of carbohydrate-deficient transferrin (CDT) revealed a mild type I CDG pattern and the presence of an abnormal transferrin glycoform containing a linear heptasaccharide consisting of one sialic acid, one galactose, one N-acetyl-glucosamine, two mannoses and two N-acetylglucosamines (NeuAc-Gal-GlcNAc-Man2-GlcNAc2), ALG2-CDG diagnostic biomarker, confirming the pathogenicity of these variants.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2024.1363558","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:44:42Z","timestamp":1714956282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Case report: Novel genotype of ALG2-CDG and confirmation of the heptasaccharide glycan (NeuAc-Gal-GlcNAc-Man2-GlcNAc2) as a specific diagnostic biomarker"],"prefix":"10.3389","volume":"15","author":[{"given":"Ivan","family":"Mart\u00ednez Duncker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Mata-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Shammas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasantha","family":"Ranatunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earnest James Paul","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Cruz Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Mora-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gildardo","family":"Zafra de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"Unit7.20","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","author":"Adzhubei","year":"2013","journal-title":"Curr. Protoc. Hum. Genet. SUPPL.76"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/brain\/awv185","article-title":"Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies","volume":"138","author":"Belaya","year":"2015","journal-title":"Brain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10545-015-9884-y","article-title":"Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG","volume":"39","author":"Bengtson","year":"2016","journal-title":"J. Inherit. Metabolic Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.21037\/atm.2018.10.45","article-title":"Congenital disorders of glycosylation","volume":"6","author":"Chang","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.20.485034","article-title":"A genome-wide mutational constraint map quantified from variation in 76,156 human genomes","author":"Chen","year":"2022","journal-title":"bioRxiv"},{"key":"B6","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/brain\/awt010","article-title":"Congenital myasthenic syndromes due to mutations in ALG2 and ALG14","volume":"136","author":"Cossins","year":"2013","journal-title":"Brain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.nmd.2021.11.012","article-title":"Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: a case report","volume":"32","author":"Ehrstedt","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13023-023-02879-z","article-title":"Congenital disorders of glycosylation (CDG): state of the art in 2022","volume":"18","author":"Francisco","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"744884","DOI":"10.3389\/fgene.2021.744884","article-title":"ALG1-CDG caused by non-functional Alternative Splicing involving a novel pathogenic complex allele","volume":"12","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2021","journal-title":"Front. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/ijms22020606","article-title":"Saafec-seq: a sequence-based method for predicting the effect of single point mutations on protein thermodynamic stability","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471142905.hg1718s86","article-title":"Glycosylation analysis for congenital disorders of glycosylation","volume":"2015","author":"Li","year":"2015","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/genes14081585","article-title":"Interplay of impaired cellular Bioenergetics and Autophagy in PMM2-CDG","volume":"14","author":"Ligezka","year":"2023","journal-title":"Genes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/nar\/gkj518","article-title":"Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods","volume":"34","author":"Mathe","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40246-016-0089-8","article-title":"A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies","volume":"10","author":"Monies","year":"2016","journal-title":"Hum. Genomics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.nmd.2013.12.010","article-title":"Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic\/myopathic syndrome","volume":"24","author":"Monies","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"129751","DOI":"10.1016\/j.bbagen.2020.129751","article-title":"Congenital disorders of glycosylation: Still \u201chot\u201d in 2020","volume":"1865","author":"Ondruskova","year":"2021","journal-title":"Biochimica Biophysica Acta - General Subj."},{"key":"B18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10719-021-09976-w","article-title":"Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis","volume":"38","author":"Papazoglu","year":"2021","journal-title":"Glycoconj. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/brainsci11010088","article-title":"Congenital disorders of glycosylation from a neurological perspective","volume":"11","author":"Paprocka","year":"2021","journal-title":"Brain Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/bioinformatics\/btw361","article-title":"STRUM: structure-based prediction of protein stability changes upon single-point mutation","volume":"32","author":"Quan","year":"2016","journal-title":"Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical genetics and Genomics and the association for molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral","volume":"43","author":"Tavtigian","year":"2006","journal-title":"J. Med. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"22498","DOI":"10.1074\/jbc.M302850200","article-title":"A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis","volume":"278","author":"Thiel","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1373\/CLINCHEM.2015.243279","article-title":"A novel N-tetrasaccharide in patients with congenital disorders of glycosylation, including asparagine-linked glycosylation protein 1, phosphomannomutase 2, and mannose phosphate isomerase deficiencies","volume":"62","author":"Zhang","year":"2016","journal-title":"Clin. Chem."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1363558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:44:44Z","timestamp":1714956284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1363558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":24,"alternative-id":["10.3389\/fgene.2024.1363558"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1363558","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,6]]},"article-number":"1363558"}}